BES_Mark.jpg
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm
March 31, 2021 19:50 ET | Bragar Eagel & Squire
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, advises that a tender offer to acquire GenMark Diagnostics, Inc....
BES_Mark.jpg
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GNMK and Encourages Investors to Contact the Firm
March 15, 2021 13:57 ET | Bragar Eagel & Squire
NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
Logo.png
Age-related Macular Degeneration Pipeline Analysis of 70+ Key Companies and 70+ Key Therapeutic Products 
March 09, 2021 20:20 ET | DelveInsight Business Research LLP
Los Angeles, USA , March 09, 2021 (GLOBE NEWSWIRE) -- Age-related Macular Degeneration Pipeline Analysis of 70+ Key Companies and 70+ Key Therapeutic Products  DelveInsight anticipates the launch...
logo-alt.png
Global Non-Invasive Prenatal Testing (NIPT) Market – Analysis and Demand with Forecast Overview to 2029 - by PMI
January 04, 2021 10:05 ET | PMI
Covina, CA, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Evolution of prenatal testing, in the form of non-invasive tests that can serve as an intermediate step between screening and invasive tests in order to...
logo.png
Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida
October 07, 2020 07:58 ET | Arch Biopartners
TORONTO, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Ministry...
logo.png
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
October 05, 2020 10:13 ET | ImmunoPhotonics, Inc.
ST. LOUIS, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers for the...
logo.png
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
October 05, 2020 04:13 ET | ImmunoPhotonics, Inc.
BERN, Switzerland, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers...
logo-alt.png
Global Systemic Lupus Erythematosus Market – Estimated to Gain Traction with Arrival of Key Pipeline Agents, with Promising Higher Efficacy than Existent Therapies - PMI
August 20, 2020 10:35 ET | PMI
Covina, CA, Aug. 20, 2020 (GLOBE NEWSWIRE) -- The report "Global Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics),...
RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment
May 28, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Tusk-logo.jpg
Tusk Therapeutics to be acquired by Roche
September 28, 2018 01:30 ET | Tusk Therapeutics Ltd
  Tusk Therapeutics to be acquired by Roche Stevenage, United Kingdom – September 28th 2018:  Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel...